Rapport Therapeutics Statistics
Total Valuation
RAPP has a market cap or net worth of $1.68 billion. The enterprise value is $1.22 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RAPP has 47.83 million shares outstanding. The number of shares has increased by 44.36% in one year.
| Current Share Class | 47.83M |
| Shares Outstanding | 47.83M |
| Shares Change (YoY) | +44.36% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 4.45% |
| Owned by Institutions (%) | 79.32% |
| Float | 31.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 84.13 |
| Forward PS | n/a |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 60.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.08, with a Debt / Equity ratio of 0.02.
| Current Ratio | 27.08 |
| Quick Ratio | 26.64 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.33% and return on invested capital (ROIC) is -19.69%.
| Return on Equity (ROE) | -28.33% |
| Return on Assets (ROA) | -19.10% |
| Return on Invested Capital (ROIC) | -19.69% |
| Return on Capital Employed (ROCE) | -25.48% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $238,095 |
| Profits Per Employee | -$1.28M |
| Employee Count | 84 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +253.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +253.21% |
| 50-Day Moving Average | 33.35 |
| 200-Day Moving Average | 27.48 |
| Relative Strength Index (RSI) | 47.76 |
| Average Volume (20 Days) | 328,527 |
Short Selling Information
The latest short interest is 3.05 million, so 6.37% of the outstanding shares have been sold short.
| Short Interest | 3.05M |
| Short Previous Month | 3.41M |
| Short % of Shares Out | 6.37% |
| Short % of Float | 9.73% |
| Short Ratio (days to cover) | 8.86 |
Income Statement
In the last 12 months, RAPP had revenue of $20.00 million and -$107.28 million in losses. Loss per share was -$2.56.
| Revenue | 20.00M |
| Gross Profit | 6.86M |
| Operating Income | -122.21M |
| Pretax Income | -107.28M |
| Net Income | -107.28M |
| EBITDA | -121.21M |
| EBIT | -122.21M |
| Loss Per Share | -$2.56 |
Full Income StatementBalance Sheet
The company has $476.78 million in cash and $10.80 million in debt, with a net cash position of $465.98 million or $9.74 per share.
| Cash & Cash Equivalents | 476.78M |
| Total Debt | 10.80M |
| Net Cash | 465.98M |
| Net Cash Per Share | $9.74 |
| Equity (Book Value) | 471.51M |
| Book Value Per Share | 9.86 |
| Working Capital | 466.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$80.30 million and capital expenditures -$411,000, giving a free cash flow of -$80.71 million.
| Operating Cash Flow | -80.30M |
| Capital Expenditures | -411,000 |
| Depreciation & Amortization | 1.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -80.71M |
| FCF Per Share | -$1.69 |
Full Cash Flow StatementMargins
| Gross Margin | 34.28% |
| Operating Margin | -611.03% |
| Pretax Margin | -536.39% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RAPP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.36% |
| Shareholder Yield | -44.36% |
| Earnings Yield | -6.38% |
| FCF Yield | -4.80% |
Analyst Forecast
The average price target for RAPP is $54.70, which is 55.49% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.70 |
| Price Target Difference | 55.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RAPP has an Altman Z-Score of 21.14 and a Piotroski F-Score of 1.
| Altman Z-Score | 21.14 |
| Piotroski F-Score | 1 |
